Julia Bruno, Farge Gaëlle, Mourlat Benoit, Mamane Carole, Bensimon Lionel, Hommel Christophe, Conan Gilles
Community Pharmacist, Lherm, France.
Outcomes Research, MSD France, Puteaux, France.
Explor Res Clin Soc Pharm. 2023 Mar 30;10:100255. doi: 10.1016/j.rcsop.2023.100255. eCollection 2023 Jun.
Human papillomavirus (HPV) vaccination coverage rate (VCR) remains low in France (37.4% in girls in 2021). The French health authority recommended in 2022 to extend vaccination competencies to additional healthcare providers (HCPs), including community pharmacists (CPs).
To understand the acceptability by general practitioners (GPs), CPs and parents of adolescents of extending vaccination competencies and to identify benefits and barriers of new vaccination pathways.
This cross-sectional research used a qualitative and quantitative approach. For the quantitative survey, GPs, CPs and parents of adolescents eligible to HPV vaccination completed an online questionnaire. Participants were asked to imagine themselves in different pathways and evaluate them.
A total of 200 GPs, 201 CPs and 800 parents were included. The level of acceptability of extending vaccination competencies to other HCPs was high in CPs (86% rated ≥7/10), but low in GPs (35%) and intermediate in parents (61%). Parents ranked first (44%) a pathway where GPs prescribed while CPs vaccinated because GPs inspire confidence as vaccine prescribers (80%) and parents prefer to be informed on vaccination by them (80%). CPs ranked first (42%) a scenario where they vaccinated after invitation of adolescents from the French National Health Insurance Fund (NHIS). They emphasized the simplicity of this scenario (94%) and the potential increase of VCR (91%), but asked to be more informed on HPV vaccination (77%) and favored television (83%) for communication campaigns.
GPs and parents, in contrast with community pharmacists, were only moderately supportive of the extension the vaccination competencies. Confidence in the HCP remains the primary factor for adherence to a vaccination pathway beyond the simplicity of the pathway. Training of CPs, traceability tool, support from authorities and communication campaigns are levers that will support CPs in their new role and contribute to increase parents' acceptability toward CPs.
在法国，人乳头瘤病毒（HPV）疫苗接种覆盖率仍然较低（2021年女孩中为37.4%）。法国卫生当局在2022年建议将疫苗接种能力扩展至更多医疗保健提供者（HCP），包括社区药剂师（CP）。
了解全科医生（GP）、CP以及青少年家长对扩展疫苗接种能力的接受度，并确定新疫苗接种途径的益处和障碍。
这项横断面研究采用了定性和定量方法。对于定量调查，符合HPV疫苗接种条件的GP、CP和青少年家长完成了一份在线问卷。参与者被要求设想自己处于不同途径并对其进行评估。
共纳入200名GP、201名CP和800名家长。CP对将疫苗接种能力扩展至其他HCP的接受程度较高（86%的评分≥7/10），但GP的接受程度较低（35%），家长的接受程度处于中等水平（61%）。家长将GP开处方而CP接种的途径列为首选（44%），因为GP作为疫苗开处方者能激发信心（80%），且家长更希望从他们那里了解疫苗接种信息（80%）。CP将法国国家医疗保险基金（NHIS）邀请青少年后由他们接种的情况列为首选（42%）。他们强调这种情况的简便性（94%）以及疫苗接种覆盖率可能提高（91%），但要求更多地了解HPV疫苗接种信息（77%），并倾向于通过电视（83%）进行宣传活动。
与社区药剂师相比，GP和家长对扩展疫苗接种能力的支持程度仅为中等。对HCP的信心仍然是坚持某种疫苗接种途径的主要因素，而非途径的简便性。对CP的培训、可追溯工具、当局的支持和宣传活动是有助于CP发挥新作用并提高家长对CP接受度的手段。
